Literature DB >> 30819813

Impaired cough suppression in chronic refractory cough.

Peter S P Cho1, Hannah V Fletcher2, Richard D Turner1,3, Caroline J Jolley1, Surinder S Birring1,2.   

Abstract

Functional brain imaging in individuals with chronic cough demonstrates reduced activation in cortical regions associated with voluntary cough suppression. Little is known about the ability of patients with chronic cough to suppress cough. This study aimed to compare the ability to voluntarily suppress cough during inhaled capsaicin challenge in participants with chronic refractory cough with that in healthy controls. In addition, this study aimed to assess the repeatability of capsaicin challenge test with voluntary cough suppression.Participants with chronic refractory cough and healthy controls underwent inhaled capsaicin challenge tests while attempting to suppress their cough responses. After 5 days, either a conventional capsaicin challenge test with no cough suppression attempt, or a repeat test with an attempt at cough suppression was performed. Threshold capsaicin concentrations required to elicit one, two and five coughs were calculated by interpolation. Objective 24-h cough frequency was measured in individuals with chronic refractory cough.Healthy controls were able to suppress capsaicin-evoked cough while participants with chronic refractory cough were not. Geometric mean±sd capsaicin dose thresholds for five coughs with (CS5) and without (C5) suppression attempts were 254.40±3.78 versus 45.89±3.95 µmol·L-1, respectively, in healthy controls (p=0.033) and 3.34±5.04 versus 3.86±5.13 µmol·L-1, respectively, in participants with chronic refractory cough (p=0.922). Capsaicin dose thresholds for triggering five coughs with self-attempted cough suppression were significantly lower in participants with chronic refractory cough than in healthy controls; geometric mean±sd 4.94±4.43 versus 261.10±4.34 µmol·L-1, respectively; mean difference (95% CI) 5.72 (4.54-6.91) doubling doses (p<0.001). Repeatability of cough suppression test in both patients and healthy controls was high; intraclass correlation coefficients of log(CS5) values 0.81 and 0.87, respectively. CS5 was associated with objective cough frequency (ρ=-0.514, p=0.029).Participants with chronic refractory cough were less able to voluntarily suppress capsaicin-evoked cough compared to healthy controls. This may have important implications for the pathophysiology and treatment of chronic cough.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 30819813     DOI: 10.1183/13993003.02203-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

Review 1.  Current Status and Future Directions of Chronic Cough in China.

Authors:  Kefang Lai; Li Long
Journal:  Lung       Date:  2020-01-07       Impact factor: 2.584

Review 2.  Cough hypersensitivity and chronic cough.

Authors:  Kian Fan Chung; Lorcan McGarvey; Woo-Jung Song; Anne B Chang; Kefang Lai; Brendan J Canning; Surinder S Birring; Jaclyn A Smith; Stuart B Mazzone
Journal:  Nat Rev Dis Primers       Date:  2022-06-30       Impact factor: 65.038

3.  Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough.

Authors:  Brendan J Canning; Qi Liu; Mayuko Tao; Robert DeVita; Michael Perelman; Douglas W Hay; Peter V Dicpinigaitis; Jing Liang
Journal:  J Pharmacol Exp Ther       Date:  2021-11-15       Impact factor: 4.402

4.  Impact of mental health and personality traits on the incidence of chronic cough in the Canadian Longitudinal Study on Aging.

Authors:  Imran Satia; Alexandra J Mayhew; Nazmul Sohel; Om Kurmi; Kieran J Killian; Paul M O'Byrne; Parminder Raina
Journal:  ERJ Open Res       Date:  2022-05-30

Review 5.  Impact and disease burden of chronic cough.

Authors:  Ha-Kyeong Won; Woo-Jung Song
Journal:  Asia Pac Allergy       Date:  2021-04-28

Review 6.  Recent progress in the management of chronic cough.

Authors:  Woo-Jung Song; Jin An; Lorcan McGarvey
Journal:  Korean J Intern Med       Date:  2020-05-20       Impact factor: 2.884

Review 7.  WAO-ARIA consensus on chronic cough - Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways.

Authors:  Philip W Rouadi; Samar A Idriss; Jean Bousquet; Tanya M Laidlaw; Cecilio R Azar; Mona Sulaiman Al-Ahmad; Anahí Yáñez; Maryam Ali Y Al-Nesf; Talal M Nsouli; Sami L Bahna; Eliane Abou-Jaoude; Fares H Zaitoun; Usamah M Hadi; Peter W Hellings; Glenis K Scadding; Peter K Smith; Mario Morais-Almeida; R Maximiliano Gómez; Sandra N González Díaz; Ludger Klimek; Georges S Juvelekian; Moussa A Riachy; Giorgio Walter Canonica; David Peden; Gary W K Wong; James Sublett; Jonathan A Bernstein; Lianglu Wang; Luciana Kase Tanno; Manana Chikhladze; Michael Levin; Yoon-Seok Chang; Bryan L Martin; Luis Caraballo; Adnan Custovic; José Antonio Ortega-Martell; Erika Jensen-Jarolim; Motohiro Ebisawa; Alessandro Fiocchi; Ignacio J Ansotegui
Journal:  World Allergy Organ J       Date:  2021-12-04       Impact factor: 4.084

8.  Clinical characteristics in adult patients with somatic cough syndrome.

Authors:  Kefang Lai; Wen Peng; Wenzhi Zhan; Jia-Xing Xie; Jing Tian; Xiao-Ping Zuo; Li Long; Jia-Man Tang; Jia-Yu Pan; Mei Jiang; Nan-Shan Zhong
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

9.  Clinical characteristics of patients with chronic cough in Guangdong, China: a multicenter descriptive study.

Authors:  Kefang Lai; Lianrong Huang; Haijin Zhao; Feng Wu; Guocui Zhen; Haiyan Deng; Wei Luo; Wen Peng; Mei Jiang; Fang Yi; Jianxin Sun; Pusheng Xu; Yuqi Zhou; Yinji Xu; Xiaoling Yuan; Yiju Zhao; Meihua Chen; Yong Jiang
Journal:  BMC Pulm Med       Date:  2021-09-27       Impact factor: 3.317

10.  Evaluation methods and influencing factors of cough sensitivity.

Authors:  Hao Mei; Wenhua Gu; Linxin Ran; Siwan Wen; Li Yu; Xianghuai Xu
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 4.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.